Theravance Biopharma

TBPH

Market cap $1.03B

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$29

44% upside

High target

positive

0 neutral

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
BTIG Julian Harrison 100% 1-yr TBPH win rate				26 Nov ‘25 4 days ago
HC Wainwright & Co Douglas Tsao 100% 1-yr TBPH win rate				11 Nov ‘25 19 days ago
B. Riley Securities Mayank Mamtani 100% 1-yr TBPH win rate				12 Sep ‘25 2 months ago